Table 4.
Causes of death, by soy product | Men (n=42 750)* | Ptrend | |||||
---|---|---|---|---|---|---|---|
First (lowest intake) | Second | Third | Fourth | Fifth (highest intake) | |||
Cancer | |||||||
Total soy products | 582 | 616 | 652 | 693 | 777 | ||
Model 2 | 1 | 0.97 (0.86 to 1.08) | 1.00 (0.89 to 1.12) | 1.01 (0.90 to 1.13) | 1.09 (0.96 to 1.22) | 0.10 | |
Fermented soy products | 647 | 593 | 624 | 731 | 725 | ||
Model 2 | 1 | 0.91 (0.81 to 1.02) | 0.92 (0.82 to 1.03) | 1.04 (0.93 to 1.17) | 0.97 (0.85 to 1.09) | 0.66 | |
Non-fermented soy | 616 | 622 | 652 | 721 | 709 | ||
Model 2 | 1 | 1.00 (0.90 to 1.13) | 1.04 (0.93 to 1.17) | 1.10 (0.98 to 1.23) | 1.06 (0.94 to 1.19) | 0.12 | |
Natto | 601 | 619 | 656 | 667 | 777 | ||
Model 2 | 1 | 1.01 (0.90 to 1.13) | 0.97 (0.86 to 1.10) | 1.00 (0.89 to 1.13) | 0.98 (0.87 to 1.11) | 0.74 | |
Miso | 601 | 619 | 656 | 667 | 777 | ||
Model 2 | 1 | 0.95 (0.85 to 1.07) | 0.97 (0.86 to 1.08) | 0.95 (0.84 to 1.06) | 1.02 (0.91 to 1.16) | 0.74 | |
Tofu | 618 | 629 | 655 | 680 | 738 | ||
Model 2 | 1 | 1.01 (0.90 to 1.13) | 1.04 (0.93 to 1.17) | 1.03 (0.92 to 1.16) | 1.09 (0.97 to 1.22) | 0.13 | |
Total cardiovascular disease | |||||||
Total soy products | 345 | 397 | 398 | 397 | 463 | ||
Model 2 | 1 | 1.03 (0.89 to 1.20) | 0.97 (0.84 to 1.13) | 0.89 (0.77 to 1.04) | 0.95 (0.82 to 1.11) | 0.18 | |
Fermented soy products | 363 | 369 | 424 | 436 | 408 | ||
Model 2 | 1 | 0.98 (0.84 to 1.14) | 1.04 (0.90 to 1.21) | 1.00 (0.85 to 1.17) | 0.82 (0.70 to 0.97) | 0.04 | |
Non-fermented soy | 419 | 348 | 386 | 396 | 451 | ||
Model 2 | 1 | 0.85 (0.74 to 0.98) | 0.91 (0.79 to 1.04) | 0.87 (0.75 to 1.00) | 0.95 (0.82 to 1.09) | 0.63 | |
Natto | 691 | 306 | 317 | 342 | 344 | ||
Model 2 | 1 | 0.86 (0.74 to 1.00) | 0.86 (0.73 to 1.00) | 0.85 (0.73 to 0.99) | 0.76 (0.65 to 0.90) | 0.002 | |
Miso | 345 | 365 | 380 | 437 | 473 | ||
Model 2 | 1 | 0.96 (0.84 to 1.13) | 0.95 (0.81 to 1.10) | 1.04 (0.90 to 1.21) | 0.95 (0.82 to 1.10) | 0.84 | |
Tofu | 425 | 348 | 381 | 406 | 440 | ||
Model 2 | 1 | 0.83 (0.72 to 0.96) | 0.89 (0.77 to 1.02) | 0.87 (0.75 to 1.00) | 0.90 (0.78 to 1.04) | 0.30 | |
Heart disease | |||||||
Total soy products | 189 | 229 | 209 | 202 | 239 | ||
Model 2 | 1 | 1.08 (0.88 to 1.31) | 0.90 (0.74 to 1.11) | 0.79 (0.64 to 0.98) | 0.82 (0.67 to 1.02) | 0.004 | |
Fermented soy products | 201 | 203 | 221 | 233 | 210 | ||
Model 2 | 1 | 0.98 (0.81 to 1.20) | 0.99 (0.81 to 1.22) | 0.97 (0.78 to 1.19) | 0.77 (0.62 to 0.97) | 0.03 | |
Non-fermented soy | 228 | 189 | 214 | 202 | 235 | ||
Model 2 | 1 | 0.83 (0.68 to 1.00) | 0.88 (0.72 to 1.07) | 0.75 (0.62 to 0.92) | 0.41 (0.67 to 0.99) | 0.03 | |
Natto | 376 | 170 | 160 | 194 | 168 | ||
Model 2 | 1 | 0.90 (0.74 to 1.10) | 0.82 (0.66 to 1.02) | 0.92 (0.75 to 1.14) | 0.71 (0.57 to 0.88) | 0.01 | |
Miso | 194 | 174 | 212 | 247 | 241 | ||
Model 2 | 1 | 0.84 (0.68 to 1.03) | 0.97 (0.79 to 1.18) | 1.06 (0.87 to 1.30) | 0.86 (0.70 to 1.06) | 0.74 | |
Tofu | 234 | 191 | 204 | 214 | 225 | ||
Model 2 | 1 | 0.81 (0.66 to 0.98) | 0.82 (0.67 to 0.99) | 0.77 (0.63 to 0.94) | 0.74 (0.61 to 0.90) | 0.005 | |
Cerebrovascular disease | |||||||
Total soy products | 128 | 144 | 155 | 170 | 183 | ||
Model 2 | 1 | 1.02 (0.80 to 1.30) | 1.04 (0.82 to 1.33) | 1.06 (0.83 to 1.36) | 1.08 (0.85 to 1.39) | 0.46 | |
Fermented soy | 126 | 147 | 169 | 175 | 163 | ||
Model 2 | 1 | 1.10 (0.86 to 1.40) | 1.16 (0.91 to 1.49) | 1.12 (0.87 to 1.44) | 0.91 (0.70 to 1.20) | 0.46 | |
Non-fermented soy | 167 | 131 | 144 | 157 | 181 | ||
Model 2 | 1 | 0.83 (0.66 to 1.05) | 0.89 (0.71 to 1.12) | 0.94 (0.74 to 1.18) | 1.07 (0.86 to 1.34) | 0.31 | |
Natto | 259 | 117 | 130 | 126 | 148 | ||
Model 2 | 1 | 0.84 (0.66 to 1.07) | 0.89 (0.69 to 1.13) | 0.78 (0.61 to 1.01) | 0.83 (0.65 to 1.07) | 0.14 | |
Miso | 125 | 160 | 143 | 157 | 195 | ||
Model 2 | 1 | 1.15 (0.90 to 1.45) | 0.94 (0.73 to 1.20) | 0.99 (0.78 to 1.27) | 1.04 (0.82 to 1.33) | 0.83 | |
Tofu | 165 | 127 | 148 | 158 | 182 | ||
Model 2 | 1 | 0.81 (0.64 to 1.03) | 0.94 (0.74 to 1.18) | 0.95 (0.75 to 1.19) | 1.08 (0.86 to 1.36) | 0.24 | |
Respiratory disease | |||||||
Total soy products | 99 | 102 | 110 | 123 | 184 | ||
Model 2 | 1 | 0.97 (0.73 to 1.28) | 1.01 (0.76 to 1.35) | 1.03 (0.78 to 1.37) | 1.36 (1.03 to 1.78) | 0.01 | |
Fermented soy products | 141 | 94 | 102 | 125 | 156 | ||
Model 2 | 1 | 0.72 (0.55 to 0.95) | 0.79 (0.60 to 1.03) | 0.88 (0.67 to 1.15) | 0.97 (0.73 to 1.28) | 0.74 | |
Non-fermented soy | 106 | 96 | 115 | 134 | 167 | ||
Model 2 | 1 | 0.96 (0.73 to 1.27) | 1.10 (0.84 to 1.44) | 1.17 (0.89 to 1.53) | 1.31 (1.00 to 1.70) | 0.02 | |
Natto | 247 | 79 | 75 | 91 | 126 | ||
Model 2 | 1 | 0.82 (0.62 to 1.07) | 0.82 (0.61 to 1.10) | 0.88 (0.66 to 1.18) | 0.96 (0.73 to 1.27) | 0.90 | |
Miso | 114 | 113 | 109 | 114 | 168 | ||
Model 2 | 1 | 0.92 (0.70 to 1.19) | 0.88 (0.67 to 1.15) | 0.90 (0.68 to 1.19) | 1.07 (0.82 to 1.40) | 0.55 | |
Tofu | 110 | 105 | 109 | 138 | 156 | ||
Model 2 | 1 | 1.00 (0.76 to 1.31) | 0.99 (0.75 to 1.30) | 1.13 (0.87 to 1.47) | 1.13 (0.87 to 1.47) | 0.23 | |
Injury | |||||||
Total soy products | 137 | 123 | 144 | 131 | 149 | ||
Model 2 | 1 | 0.82 (0.64 to 1.05) | 0.91 (0.71 to 1.16) | 0.77 (0.59 to 0.99) | 0.85 (0.66 to 1.10) | 0.22 | |
Fermented soy products | 124 | 125 | 138 | 149 | 148 | ||
Model 2 | 1 | 0.91 (0.71 to 1.18) | 0.91 (0.70 to 1.18) | 0.91 (0.70 to 1.19) | 0.86 (0.65 to 1.13) | 0.36 | |
Non-fermented soy | 149 | 141 | 134 | 115 | 145 | ||
Model 2 | 1 | 1.01 (0.80 to 1.28) | 0.97 (0.76 to 1.23) | 0.81 (0.63 to 1.04) | 1.01 (0.79 to 1.29) | 0.50 | |
Natto | 186 | 124 | 136 | 121 | 117 | ||
Model 2 | 1 | 1.10 (0.86 to 1.41) | 1.17 (0.90 to 1.52) | 0.99 (0.75 to 1.30) | 0.96 (0.72 to 1.27) | 0.53 | |
Miso | 129 | 111 | 128 | 136 | 180 | ||
Model 2 | 1 | 0.81 (0.62 to 1.04) | 0.82 (0.63 to 1.05) | 0.84 (0.65 to 1.08) | 1.00 (0.78 to 1.28) | 0.76 | |
Tofu | 147 | 145 | 127 | 124 | 141 | ||
Model 2 | 1 | 1.05 (0.83 to 1.33) | 0.93 (0.73 to 1.19) | 0.89 (0.69 to 1.14) | 1.00 (0.78 to 1.28) | 0.57 |
Model 2 is adjusted for age, area, smoking, frequency of alcohol intake, body mass index, sports or physical exercise, history of diabetes or taking drugs for diabetes, taking antihypertensives, health check-up, total energy intake, and intake of green tea, coffee, fish, meat, fruit, and vegetables.
Except for natto intake, the first to fifth categories comprised 8550 men. The first category of natto intake included participants who did not eat natto (n=12450). The remaining participants were divided into quarters and are shown in the second to fifth categories (7575 in men).